TABLE 3.
Diversity of immune effects by paraben EDCs.
Dose (μg/L) | Species | Cell type | Immune impact | ||
In vitro | |||||
BP | 2 (×108) (Matsuoka et al., 2018) (Indirect/sensitization) | Mouse | Brachial LN cells | ↑ | IL-4 and IFN-γ |
Dendritic cells | ↑ | Skin to dLN trafficking | |||
1.17 (×10–2) (Bairati et al., 1994) | Human | Lymphocytes | ↓ | Lysozyme release | |
HP-DP | 2,360–2,780 (Uramaru et al., 2014) | Rat | Peritoneal mast cells | ↑ | Histamine release |
PP-DDP | 20,800–30,600a (Uramaru et al., 2014) | Rat | Peritoneal mast cells | ↑ | Histamine release |
IPP | 20,800 (Uramaru et al., 2014) | Rat | Peritoneal mast cells | ↑ | Histamine release |
In vivo | |||||
BP | 200 mg/kg (Hegazy et al., 2015) | Rat (M) | N/A (brain lysates) | ↑ | NO, IL-6 and TNF-α |
↓ | IL-1β mRNA |